The average price reduction of COVID-19, rare diseases and other drugs in medical insurance has exceeded 60% -- Interpretation of the latest version of the national medical insurance drug catalog
The average price reduction of drugs newly admitted to medical insurance, negotiation and bidding, such as Azovudine and other COVID-19 therapeutic drugs, reached 60.1%, and it is estimated that the b ...
Policy 2023-01-20